After a long, cash-strapped journey, French biotech Abivax has presented top-line data from the twin phase 3 trials of its lead ulcerative colitis candidate.  | After a long, cash-strapped journey, ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating ...

Amylyx Pharmaceuticals, Inc. today announced the presentation of new exploratory analyses from the Phase 2 PREVENT and Phase 2 b clinical trials of avexitide, an investigational, first-in-class ...

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

Decentralized Clinical Trials (DCTs) are transforming how we collect clinical data, but this evolution brings unprecedented challenges in data quality, complexity, and integration.

ProKidney announced positive topline results from the Phase 2 REGEN-007 trial, demonstrating significant eGFR improvements with rilparencel treatment.

About the Phase 3 REGEN-006 (PROACT 1) Clinical Trial REGEN-006 is an ongoing Phase 3, randomized, blinded, sham controlled safety and efficacy study of rilparencel in subjects with advanced CKD ...

A wide variability in breast cancer (BC) risk and outcomes across ethnicities has been described. 1 - 3 Despite the well-documented influence of ethnicity on BC incidence, genomic features, treatment ...

Phase 2 REGEN-007 Overview and Topline Results REGEN-007 is a multi-center Phase 2 open-label 1:1 randomized two-arm trial in patients with diabetes, CKD, and an estimated glomerular filtration ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with significant health benefits.